<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-dextroamphetamine.xml</id>
  <title>Recalls Watch: Dextroamphetamine</title>
  <link rel="self" href="https://recalls.watch/feed/substance-dextroamphetamine.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-07-08T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99319/</id>
    <title>Lannett Company Inc.: Dextroamphetamine Saccharate</title>
    <link href="https://recalls.watch/recall/fda/99319/"/>
    <updated>2026-07-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97504/</id>
    <title>Granules Pharmaceuticals Inc.: Dextroamphetamine Saccharate and 4 more</title>
    <link href="https://recalls.watch/recall/fda/97504/"/>
    <updated>2025-10-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications:</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97461/</id>
    <title>Lannett Company Inc.: Dextroamphetamine Saccharate</title>
    <link href="https://recalls.watch/recall/fda/97461/"/>
    <updated>2025-09-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95701/</id>
    <title>Noven Pharmaceuticals Inc: Xelstrym</title>
    <link href="https://recalls.watch/recall/fda/95701/"/>
    <updated>2024-11-27T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93786/</id>
    <title>Azurity Pharmaceuticals, Inc.: Zenzedi</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93786"/>
    <updated>2024-02-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Mix-up</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroam/</id>
    <title>Azurity Pharmaceuticals, Inc.: Zendedi: dextroamphetamine sulfate tablets, 30 mg</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate"/>
    <updated>2024-01-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Mislabeled package</summary>
  </entry>
</feed>
